(Q37348685)

19 August 2017

C3 glomerulopathy: consensus report (English)

1 reference

Santiago Rodriguez de Córdoba

19 August 2017

5 references

13 March 2019

9 October 2019

27 November 2019

29 May 2020

14 October 2020

28

1 reference

Véronique Frémeaux-Bacchi

19 August 2017

15

Véronique Frémeaux-Bacchi

1 reference

19 August 2017

Daniel P Gale

16

0 references

Matthew C Pickering

Matthew C Pickering

1

0 references

Aude Servais

Aude Servais

29

0 references

Richard J Smith

Richard J Smith

4

0 references

V Michael Holers

20

V Michael Holers

1 reference

19 August 2017

25

Cynthia C Nast

1 reference

19 August 2017

Vivette D D'Agati

2

1 reference

19 August 2017

Carla M Nester

3

1 reference

19 August 2017

Mark Haas

5

1 reference

19 August 2017

Gerald B Appel

6

1 reference

19 August 2017

Charles E Alpers

7

1 reference

19 August 2017

Ingeborg M Bajema

8

1 reference

19 August 2017

Camille Bedrosian

9

1 reference

19 August 2017

Michael Braun

10

1 reference

19 August 2017

Mittie Doyle

11

1 reference

19 August 2017

Fadi Fakhouri

12

1 reference

19 August 2017

Fernando C Fervenza

13

1 reference

19 August 2017

Agnes B Fogo

14

1 reference

19 August 2017

Elena Goicoechea de Jorge

17

1 reference

19 August 2017

Gene Griffin

18

1 reference

19 August 2017

Claire L Harris

19

1 reference

19 August 2017

Sally Johnson

21

1 reference

19 August 2017

Peter J Lavin

22

1 reference

19 August 2017

Nicholas Medjeral-Thomas

23

1 reference

19 August 2017

B Paul Morgan

24

1 reference

19 August 2017

Laure-Hélène Noel

26

1 reference

19 August 2017

D Keith Peters

27

1 reference

19 August 2017

Sanjeev Sethi

30

1 reference

19 August 2017

Wen-Chao Song

31

1 reference

19 August 2017

Paul Tamburini

32

1 reference

19 August 2017

Joshua M Thurman

33

1 reference

19 August 2017

Michael Zavros

34

1 reference

19 August 2017

H Terence Cook

35

1 reference

19 August 2017

language of work or name

English

0 references

publication date

30 October 2013

1 reference

19 August 2017

1 December 2013

5 references

13 March 2019

9 October 2019

27 November 2019

29 May 2020

14 October 2020

5 references

19 August 2017

13 March 2019

9 October 2019

27 November 2019

14 October 2020

84

1 reference

19 August 2017

1079-1089

1 reference

19 August 2017

6

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

19 August 2017

4 references

13 March 2019

9 October 2019

27 November 2019

https://scigraph.springernature.com/pub.10.1038/ki.2013.377

14 October 2020

exact match

0 references

cites work

A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Toward a working definition of C3 glomerulopathy by immunofluorescence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Treatment options for C3 glomerulopathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Eculizumab for the Treatment of Dense-Deposit Disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Eculizumab in a patient with dense-deposit disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Eculizumab for dense deposit disease and C3 glomerulonephritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Causes of alternative pathway dysregulation in dense deposit disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Allelic variants of complement genes associated with dense deposit disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Dense deposit disease associated with monoclonal gammopathy of undetermined significance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

C3 glomerulopathy: a new classification

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Dense deposit disease is not a membranoproliferative glomerulonephritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Pathology after eculizumab in dense deposit disease and C3 GN.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842953

Anti-factor B autoantibody in dense deposit disease

3 December 2018

1 reference

12 December 2020

Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies

1 reference

12 December 2020

Anti-factor H antibody affecting factor H cofactor activity in a patient with dense deposit disease.

1 reference

12 December 2020

Acute renal failure in dense deposit disease: recovery after plasmapheresis

1 reference

12 December 2020

Identifiers

DOI

10.1038/KI.2013.377

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference

19 August 2017

1 reference